905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III

Increased prevalence of anemia among recently immigrated female South Asian college students A cross sectional study from three primary care clinics in a college town

The impact of immune thrombocytopenia on oral health Let s talk

Quality of life and symptom burden in PNH A real world study on the impact of treatment access

Clinico pathological profile and treatment patterns of immune mediated aplastic anemia in resource constrained settings – an analysis from the aplastic anemia registry of India

Real world treatment patterns and clinical outcomes of therapies in primary immune thrombocytopenia

A US retrospective observational Study of rituximab initial and retreatment in patients with warm autoimmune hemolytic anemia wAIHA

Clinical outcomes associated with opioid use disorder in hospitalized patients with venous thromboembolism

Association of opioid use disorder and thrombotic events in hospitalized patients A national inpatient database study

Complete blood count monitoring for patients on anticoagulation with direct oral anticoagulants for atrial fibrillation and or venous thromboembolism

Sustained improvements in patient reported outcomes after intravenous efgartigimod in adults with primary immune thrombocytopenia in a Phase 3 clinical trial ADVANCE IV and the first 52 weeks in its open label extension study ADVANCE IV

Mortality trends in patients with co occurring chronic kidney disease and venous thromboembolism in the United States A 25 year CDC wonder analysis 1999–2023

Survival outcomes of patients with secondary hemophagocytic lymphohistiocytosis at two academic medical centers in the United States

Real world safety of sutimlimab in patients with CAD CAS A multinational multi center observational prospective cohort Study

Real world evidence of treatment patterns in hereditary hemorrhagic telangiectasia

Mortality patterns and geographic variation in acquired hemophilia A among Medicare beneficiaries in the United States

Prevalence and demographics of autoimmune hemolytic anemia in the United States

Real world analysis of ravulizumab safety and effectiveness in advanced age patients with paroxysmal nocturnal hemoglobinuria Insights from the international PNH registry

Patient reported outcomes of avatrombopag for chronic immune thrombocytopenia Interim analysis of the Phase 4 adopt study

Incidence and clinical outcomes of hematologic immune related toxicities in patients with solid malignancies treated with immune checkpoint inhibitors

Health state utility values in congenital thrombotic thrombocytopenic purpura cTTP A vignette based valuation Study in the UK general population

Paradoxical venous thromboembolism in immune thrombocytopenia A national study of mortality anticoagulation gaps and racial disparities

Evaluating the risk of non melanoma skin cancer in patients with porphyria cutanea tarda A retrospective cohort study using real world data

Real world outcomes of sutimlimab in cold agglutinin disease A multicenter trinetx analysis